Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Martin Makary

FDA won’t approve COVID shot for healthy, non-elderly population - Roll Call

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials.

Roll Call

FDA will approve COVID-19 vaccine only for older adults and high-risk groups – a public health expert explains the new rules

On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.

The Conversation

The Trump administration is defending abortion pill access in court. What?

It may seem a victory to some, but experts worry a win will allow the government to be coy about future attacks

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’

Rare admonition from a sector that has largely been silent in the face of the second Trump administration

The Guardian - US

HHS to cut 10,000 jobs, ‘streamline’ operations - Roll Call

The department outlined plans to cut 10,000 jobs, in addition to the about 10,000 employees who left voluntarily earlier this year.

Roll Call

Trump administration at ‘war’ with mRNA technology: scientists alarmed vaccine skeptics could kill research

Public health experts are sounding the alarm over recent move by the NIH to collect information about funding for research into mRNA technology

The Guardian - US

Senate confirms Makary for FDA commissioner - Roll Call

FDA pick, a former Johns Hopkins surgeon, seen as a less controversial nomination than some of Trump's other HHS subagency selections.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Congress returns for three-week sprint session - Roll Call

Both the House and Senate come back from recess this week to begin a busy three-week period that’s expected to focus on Republicans’ budget reconciliation agenda, including extending and expanding tax cuts and tightening immigration policy. The top items on the House agenda this week, meanwhile, will include more measures…

Roll Call

Makary tells Senate panel he plans to review FDA job cuts - Roll Call

FDA nominee Martin Makary was asked about abortion drugs, vaccine panels during a Senate hearing on his bid to lead the agency.

Roll Call

FDA pick may differ from HHS head RFK Jr. in some key areas - Roll Call

Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health issues.

Roll Call

Trump's post-COVID brain drain

Donald Trump is out for COVID revenge

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

the Food and Drug Administration

177 stories

Johns Hopkins University

117 stories

HELP

110 stories

The National Institutes of Health

106 stories

Bio

32 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.